Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KD Study
NCT04861051Phase 1Recruiting
- Sponsor
- Stanford University
- Start
- Jul 2021
- Primary completion
- Aug 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ketamine, sponsored by Stanford University. Primary endpoint: Number of participants with dissociative events at 1 week. Started Jul 2021; status: recruiting.
02
Drugs
ketamine
Beyond the preview
Go deeper on NCT04861051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04861051.